Perampanel
- Generic Name
- Perampanel
- Brand Names
- Fycompa
- Drug Type
- Small Molecule
- Chemical Formula
- C23H15N3O
- CAS Number
- 380917-97-5
- Unique Ingredient Identifier
- H821664NPK
- Background
Perampanel is a noncompetitive AMPA glutamate receptor antagonist. It is marketed under the name Fycompa™ and is indicated as an adjunct in patients over 12 years old for the treatment of partial-onset seizures that may or may not occur with generalized seizures. The FDA label includes an important black-boxed warning of serious or life-threatening behaviora...
- Indication
Perampanel is indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in epileptic patients four years of age and older. It is also indicated as an adjunct in the treatment of primary generalized tonic-clonic seizures in epileptic patients aged 12 years and older.
- Associated Conditions
- Epilepsy, Primary Generalized Tonic-Clonic Seizures, Partial-Onset Seizures
- Associated Therapies
- -
4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures
- First Posted Date
- 2006-08-24
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 138
- Registration Number
- NCT00368472
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.